FibroGen, Inc. , a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
Fibrogen stock last closed at $1.12, up 2.75% from the previous day, and has decreased 93.21% in one year. It has underperformed other stocks in the Biotechnology industry by 0.7 percentage points. Fibrogen stock is currently +236.34% from its 52-week low of $0.33, and -94.25% from its 52-week high of $19.47.
As of Apr 30, 2024, there are 98.77M FGEN shares outstanding. The market value of FGEN is $110.62M. In the last 24 hours, 1.12M FGEN shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy FGEN shares.
In our opinion, eToro is the best brokerage. Here's why:
Get $10 towards your stock purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in FGEN today.
Now that you have opened your account on the best stock trading app, you can securely and quickly fund your account:
Check out the video below if you need help transferring funds into your investment account.
After you have figured out the best place to buy Fibrogen stock, it's very important to evaluate their stock prior to investing, so you can comprehend the risk as well as the upside.
WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.
You can see all of the due diligence checks on FGEN's stock page.
You can use many financial metrics, analyses, models, and charts to gauge FGEN's true value.
You can access additional valuation research on FGEN's stock here.
You can dig deeper into what analysts are projecting on the Fibrogen stock forecast page.
Last year, FGEN revenue was $147.75M. During the past five year, FGEN's revenue has increased by -7.05% per year. This was slower than the Biotechnology industry average of 28.43%.
Dive into FGEN's earnings and revenue performance here.
In the last year, executives and large shareholders at FGEN have sold more shares than they have bought.
Thane Wettig, CEO of FGEN, was the latest FGEN insider to sell. They sold $2,017.56 worth of FGEN stock on Mar 22, 2024.
Learn more about who owns FGEN shares here.
No, Fibrogen doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two main options:
Press the Open button and eToro will place your order.
If you want more assistance buying stocks on eToro, click the helpful video below:
Now that you own some FGEN shares, you'll want to keep up with your investment.
Create a watchlist to keep tabs on your FGEN stock.
To summarize, here are the 6 steps to buy Fibrogen stock:
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Fibrogen, click the button below.